- Early high efficacy mulitple sclerosis treatment: therapeutic success despite safety barriers2023 | First Faculty of Medicine
- Ocrelizumab since the first multiple sclerosis attack - a milestone in reimbursement criteria2022 | First Faculty of Medicine
- High efficacy treatment since the first attack - an important step in the treatment of multiple sclerosis?2023 | First Faculty of Medicine